Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
559 News Items found
Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.
In the News
New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.
Pictured: Michael Foley
Announcement
Michael Foley Named Director of Tri-Institutional Therapeutics Discovery Institute

A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.
Pictured: Joan Massagué
Announcement
Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.
Pictured: Stephen Long & Alexandria Miller
Profile
At Work: Structural Biologist Stephen Long

Stephen Long works to understand how proteins work by determining what they look like in three dimensions.
Pictured: Craig Thompson
Event
Watch Webcast of “Major Trends” Seminar — Annual Event for High School Students

Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Announcement
Innovative Partnership Will Speed Drug Discovery and Development

Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.
Pictured: Emily Foley
Profile
At Work: Cell Biologist Emily Foley

Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.
Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
Immune Cells in the Brain Could be Enlisted to Fight Glioblastoma

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Pictured: James E. Rothman, Thomas C. Südhof & Randy W. Schekman
Honors
Former Memorial Sloan Kettering Researcher James Rothman Among Nobel Prize Winners

James Rothman, who receives this year’s Nobel Prize in Physiology or Medicine together with Randy Schekman and Thomas Südhof, conducted more than a decade of his seminal research at Memorial Sloan Kettering.